Status:

TERMINATED

Single-stage Surgery Using the BI300 Implant

Lead Sponsor:

Radboud University Medical Center

Collaborating Sponsors:

Cochlear Bone Anchored Solutions

Conditions:

Hearing Impaired Children

Hearing Impairment, Conductive

Eligibility:

All Genders

4-9 years

Brief Summary

Over the last few decades, the classical two-stage surgical procedure for inserting bone-anchored hearing implants (BAHIs) has been modified in adults into a single-stage procedure. This approach has ...

Detailed Description

General description: A prospective comparative study with historical control group will be performed.The test group will consist of 22 children aged 4-9 years old who are found to be suitable candida...

Eligibility Criteria

Inclusion

  • Inclusion Criteria test group
  • Age 4-9 years
  • Indication for percutaneous bone-anchored hearing implant surgery with a BI300 implant
  • Insertion using the linear incision technique
  • Inclusion criteria Control group:
  • Children who underwent implantation of a wide diameter implant using two-stage surgery between 2012 and 2018 at the Radboudumc
  • Age 4-9 at the time of surgery
  • Linear incision technique was used during surgery
  • Exclusion Criteria Test group
  • Inability to show up at all follow-up visits
  • Patients undergoing re-implantation
  • Diseases, syndromes or treatments known to compromise the bone quality at the implant site, e.g. radiotherapy, osteoporosis, diabetes mellitus.
  • Insufficient bone thickness ≤1mm, since conversion to two-stage surgery will be advocated
  • Exclusion Criteria Control group
  • Follow-up duration less than 1 year.
  • Diseases, syndromes or treatments known to compromise the bone quality at the implant site, e.g. radiotherapy, osteoporosis, diabetes mellitus (at moment of implantation)

Exclusion

    Key Trial Info

    Start Date :

    September 1 2019

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    March 25 2025

    Estimated Enrollment :

    70 Patients enrolled

    Trial Details

    Trial ID

    NCT04038216

    Start Date

    September 1 2019

    End Date

    March 25 2025

    Last Update

    November 18 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Radboudumc

    Nijmegen, Gelderland, Netherlands, 6500hb